NewAmsterdam Pharma Company NV (NAMS) Q2 2023 Earnings

30AugExpected
Oct 22
Q4 2022
Q1 2023
Q2 2023
-1.14
-0.76
-0.38
0

Details

Expected EPS
-0.4482
Actual EPS
0
Surprise EPS
0.45
Surprise Percent
+100%

Description

NewAmsterdam Pharma Company NV (NAMS) will report earnings of for Q2 2023 on August 30, 2023.

0 Comments

Share your thoughts